Martin Landray is Chief Executive of Protas (www.protas.co.uk), a non-profit company focused on transforming the ability of clinical trials to address major public health conditions, through the use of smart design, effective use of data and technology, and improved policy and regulation. As Professor of Medicine & Epidemiology at University of Oxford, he has over 20 years' experience of leading large trials of treatments for cardiovascular and kidney disease. He co-leads the RECOVERY trial, the world’s largest trial of treatments for COVID-19, which has identified 4 effective treatments for severe COVID-19, including the cheap steroid drug, dexamethasone, which has now saved an estimated 1 million lives worldwide. He is now applying that experience and approach to substantially reduce the costs, improve the quality, and increase the accessibility of clinical trials to meet the needs of those affected by other common, high priority conditions. He was a lead contributor to the G7 100 Days Mission for Pandemic Preparedness. In June 2021, he was knighted for services to public health and science.
